Skip to main content

Call for Papers

20th Anniversary Collection

We are excited to announce the 20th Anniversary issue of journal AIDS Research & Therapy. We invite manuscripts focused on latest research that may influence policy into curbing epidemic.

This collection is no longer accepting submissions

COVID-19 and HIV: clinical presentation, outcomes and impact on clinical services

This new thematic series aims to explore the clinical presentation and outcomes of COVID-19 in people with HIV, and the impact of COVID-19 on services and treatment outcomes for people living with HIV, in both high- and low-resource settings.

Currently open for submissions - submit to the series here

Treatment outcomes and paving the way for an HIV cure in Low and Middle Income Countries

Discussion of HIV treatment outcomes in LMICs has historically been neglected, even though it is in these countries that a cure is most crucial. This series covers the ways treatment outcomes can be improved along the way to a HIV cure in states defined as LMICs by the WHO.

Currently open for submissions - submit to the series here

Spatial inequality, infectious diseases and disease control

Cross-journal collection

This collection focuses on emerging infectious diseases in humans and animals, including the impact of antimicrobial resistance, and brings together research that investigates the relationship between spatial inequalities of all kinds and the impact and prevalence of these infectious diseases. This collection also welcomes papers that seek solutions towards disease control across areas with particularly unequal distribution of resources and opportunities. 

Currently open for submissions - submit to the series here

Featured Article: HIV gp120/Tat protein-induced epithelial–mesenchymal transition promotes the progression of cervical lesions

New Content Item

Human immunodeficiency virus (HIV) infection is associated with an elevated incidence of cervical cancer, and accelerated disease progression, but the underlying mechanisms are not well understood. This study aimed to investigate the relationship between HIV infection and epithelial–mesenchymal transition (EMT) in cervical cancer.


SARS-CoV-2 and COVID-19

Find a selection of articles published across Springer Nature, as well as additional commentary and books relevant to SARS-CoV-2 and COVID-19 research.

Aims and scope

AIDS Research and Therapy publishes studies of basic, translational, clinical, epidemiological, behavioral and educational science addressing treatment and prevention of HIV/AIDS and associated conditions. This includes studies of disease pathogenesis, novel treatment strategies and the impacts of established treatment regimans. 

Announcing the launch of In Review

AIDS Research and Therapy, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:

  • Share their work with fellow researchers to read, comment on, and cite even before publication
  • Showcase their work to funders and others with a citable DOI while it is still under review
  • Track their manuscript - including seeing when reviewers are invited, and when reports are received 

Dr Barbara Castelnuovo - Editor in Chief

Dr Barbara Castelnuovo is an Italian/Ugandan clinical researcher. She is a specialist in Infectious Diseases trained at the University of Milan, with a PhD in Medical Sciences from the University of Antwerp. She has worked as an HIV specialist at the Infectious Diseases Institute, Makerere University, Uganda since 2004 and she is currently the Head of the Research Department.

Dr Castelnuovo has designed and implemented several clinical observational studies, and clinical trials. Her research interest are HIV long term outcomes, models of care and research capacity building. 

Dr Patricia Price - Editor in Chief

A/Prof Patricia Price is an Adjunct Principal Research Fellow at Curtin University, coordinating research initiatives at Curtin University in Western Australia and at the University of Indonesia. She has published over 260 papers in international journals.

Current projects address how the varied manifestations and consequences of CMV infection arise from the infection of very few cells – evaluating the roles of immune activation, CMV burden and NK cells in healthy aging donors, HIV patients and renal transplant recipients. Recent studies in collaboration with Dr Silvia Lee address the potential of γδ T-cells to mediate the effects of CMV on cardiovascular and neurocognitive health. The group are now studying variations in HCMV-encoded homologues of immune-related genes in clinical samples.

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.1
    5-year Journal Impact Factor: 2.4
    Source Normalized Impact per Paper (SNIP): 0.837
    SCImago Journal Rank (SJR): 0.872

    Speed 2023
    Submission to first editorial decision (median days): 8
    Submission to acceptance (median days): 117

    Usage 2023
    Downloads: 682,500
    Altmetric mentions: 671